HERTAB 250MG TABLET

Form: Tablets

Pack Size: 30 TABLETS

Marketed by: HETERO HEALTHCARE LTD (ONCOLOGY DIV)

MRP: ₹2232.00

HETERO HEALTHCARE LTD (ONCOLOGY DIV): Hertab 250MG Tablet, 30 tablets, salt lapatinib 250mg. NPPA has revised its MRP from Rs 7,166 to Rs 2,232 (69% lower) with effect from 09-11-2026; trade rate Rs 1,700.57. Group: HER2/EGFR tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Cipla, Natco, Neon, Novartis, Reliance Life Sciences and others. Handling/counselling: take on an empty stomach, at least one hour before or after food. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.